This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Encinitas's Dr. Edward McClay Is Selected For "America's Top Doctors® For Cancer."

Dr. Edward McClay , a Board Certified Encinitas , CA physician specializing in Medical Oncology, has been selected for America's Top Doctors® for Cancer by Castle Connolly Medical Ltd.

ENCINITAS, Calif., Jan. 18, 2013 /PRNewswire-USNewswire/ -- Castle Connolly Medical Ltd., America's trusted source for identifying Top Doctors, has published its 8th annual edition of America's Top Doctors® for Cancer and Encinitas's Edward McClay , MD has been selected for inclusion.

(Photo: http://photos.prnewswire.com/prnh/20130118/DC44911)

The 8th edition of America's Top Doctors for Cancer includes over 2,600 top cancer care physicians in the United States. Selected physicians, including Dr. McClay, are among the top 1% of cancer doctors in over 40 specialties and subspecialties for the care and treatment of cancer.

Castle Connolly Top Doctors® for Cancer are selected each year by Castle Connolly Medical Ltd. after being nominated by peers in an online nomination process. Nominations are open to all board certified MDs and DOs and each year tens of thousands of physicians cast many tens of thousands of nominations. Nominated physicians are selected by the Castle Connolly physician-led research team based on criteria including medical education, training, hospital appointments, disciplinary histories and much more.

About Edward McClay: a short profile by and about the honoree:

Dr. McClay is the director of the Institute for Melanoma Research & Education and he is a founding member of California Cancer Associates for Research and Excellence (cCARE). He has conducted both clinical and laboratory research in malignant melanoma as well as other cancers. He has authored and co-authored more than 100 articles and abstracts published in national and international journals. Additionally, he written more than 10 book chapters and together with his wife, Mary-Eileen, co-authored a book entitled "100 Questions and Answers about Malignant Melanoma and other Skin Cancers."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,132.70 -81.72 -0.45%
S&P 500 2,104.50 -6.24 -0.30%
NASDAQ 4,963.5270 -24.3630 -0.49%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs